Dr Charmaine Gittleson is a senior executive with international experience as a pharmaceutical physician and enterprise manager in pharmaceutical drug development, governance and risk management.
During her 15-year tenure with global ASX-listed specialty biotechnology company CSL, Dr Gittleson had accountability for clinical research, medical safety, medical and patient-related ethics for development and on market programs, providing leadership in strategic product development, planning and implementation across multiple therapeutic and rare disease areas. She also held a range of leadership roles including as senior director, head of safety and clinical development in Melbourne, vice president of clinical strategy and senior vice president of clinical development in Pennsylvania, and chief medical officer in Melbourne. She retired from corporate roles in 2020.
Dr Gittleson has been a scientific speaker at multiple medical conferences and regulatory workshops (FDA and EMA); and a keynote speaker at Women in Pharma & Leadership conferences for Women in ASX200-listed companies in 2017, 2018 and 2019.
She is a qualified medical physician and holds a Bachelor of Science and a Bachelor of Medicine and Surgery from the University of Witwatersrand, an Australian Medical Council Qualification, and is a graduate of the Australian Institute of Company Directors and Stanford University’s Company Directors Course.
